Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Élie

Showing results (91-100 of 144) with videos related to

Pageof 15
Sort By:
Pharmacological Research|March 11, 2020
Cell-penetrating pepducins targeting the neurotensin receptor type 1 relieve painRebecca L Brouillette, Élie Besserer-Offroy, Christine E Mona, et al.
Respiration; International Review of Thoracic Diseases|October 28, 2015
Lymphoproliferative Disorders after Lung Transplantation: Clinicopathological Characterization of 16 Cases with Identification of Very-Late-Onset FormsVincent Thomas de Montpréville, Jérôme Le Pavec, François Le Roy Ladurie, et al.
Journal of Medicinal Chemistry|July 20, 2016
Structure-Activity Relationship and Signaling of New Chimeric CXCR4 AgonistsChristine E Mona, Élie Besserer-Offroy, Jérôme Cabana, et al.
Medicine|November 5, 2004
The prognosis of acute respiratory failure in critically ill cancer patientsÉlie Azoulay, Guillaume Thiéry, Sylvie Chevret, et al.
Annals of Diagnostic Pathology|May 23, 2020
Non-small cell lung carcinomas with CTNNB1 (beta-catenin) mutations: A clinicopathological study of 26 casesVincent Thomas de Montpréville, Ludovic Lacroix, Etienne Rouleau, et al.
Plos One|May 17, 2023
The oldest plans to scale of humanmade mega-structuresRémy Crassard, Wael Abu-Azizeh, Olivier Barge, et al.
Pharmacological Research|June 1, 2024
Discovery of a CCR2-targeting pepducin therapy for chronic painÉlora Midavaine, Rebecca L Brouillette, Elizabeth Théberge, et al.
Organic & Biomolecular Chemistry|December 8, 2016
Structure-activity relationship of novel macrocyclic biased apelin receptor agonistsAlexandre Murza, Xavier Sainsily, Jérôme Côté, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 23, 2026
Improved brain penetration of neurotensin(8-13) via blood-brain barrier shuttle conjugation underlies strong analgesiaCamille Lagard, Jérôme Côté, Nathan Meneboo, et al.
Behavioural Brain Research|February 19, 2021
Metabolically stable neurotensin analogs exert potent and long-acting analgesia without hypothermiaMélanie Vivancos, Roberto Fanelli, Élie Besserer-Offroy, et al.
Pageof 15

Showing results (91-100 of 144) with videos related to

Sort By:
Pageof 15
Pharmacological Research|March 11, 2020
Cell-penetrating pepducins targeting the neurotensin receptor type 1 relieve painRebecca L Brouillette, Élie Besserer-Offroy, Christine E Mona, et al.
Respiration; International Review of Thoracic Diseases|October 28, 2015
Lymphoproliferative Disorders after Lung Transplantation: Clinicopathological Characterization of 16 Cases with Identification of Very-Late-Onset FormsVincent Thomas de Montpréville, Jérôme Le Pavec, François Le Roy Ladurie, et al.
Journal of Medicinal Chemistry|July 20, 2016
Structure-Activity Relationship and Signaling of New Chimeric CXCR4 AgonistsChristine E Mona, Élie Besserer-Offroy, Jérôme Cabana, et al.
Medicine|November 5, 2004
The prognosis of acute respiratory failure in critically ill cancer patientsÉlie Azoulay, Guillaume Thiéry, Sylvie Chevret, et al.
Annals of Diagnostic Pathology|May 23, 2020
Non-small cell lung carcinomas with CTNNB1 (beta-catenin) mutations: A clinicopathological study of 26 casesVincent Thomas de Montpréville, Ludovic Lacroix, Etienne Rouleau, et al.
Plos One|May 17, 2023
The oldest plans to scale of humanmade mega-structuresRémy Crassard, Wael Abu-Azizeh, Olivier Barge, et al.
Pharmacological Research|June 1, 2024
Discovery of a CCR2-targeting pepducin therapy for chronic painÉlora Midavaine, Rebecca L Brouillette, Elizabeth Théberge, et al.
Organic & Biomolecular Chemistry|December 8, 2016
Structure-activity relationship of novel macrocyclic biased apelin receptor agonistsAlexandre Murza, Xavier Sainsily, Jérôme Côté, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 23, 2026
Improved brain penetration of neurotensin(8-13) via blood-brain barrier shuttle conjugation underlies strong analgesiaCamille Lagard, Jérôme Côté, Nathan Meneboo, et al.
Behavioural Brain Research|February 19, 2021
Metabolically stable neurotensin analogs exert potent and long-acting analgesia without hypothermiaMélanie Vivancos, Roberto Fanelli, Élie Besserer-Offroy, et al.
Pageof 15